期刊文献+

pI3K、p-Akt和PTEN在鼻咽癌中的表达及意义 被引量:3

Expression of PI3K,p-Akt and PTEN in nasopharyngeal carcinoma and their significance
下载PDF
导出
摘要 目的观察鼻咽癌(NPC)组织中pI3K、p-Akt和PTEN表达,探讨它们在鼻咽癌发生中的作用。方法应用免疫组化方法检测60例NPC组织和23例鼻咽部慢性炎症组织中pI3K、p-Akt和PTEN的表达。结果NPC与慢性炎症组pI3K的表达率分别为86.7%(52/60)和60.9%(14/23)(P<0.05);p-Akt表达率分别为76.7%(46/60)和47.8%(11/23)(P<0.05);PTEN的表达率分别为41.7%(25/60)和65.2%(15/23)(P<0.01)。pI3K/p-Akt表达率NPC组明显高于慢性炎症组;PTEN表达率NPC组明显低于慢性炎症组,二组表达均与PTEN表达呈负相关。结论pI3K/Akt信号通路的激活、PTEN的抑制,可能在鼻咽癌的发生中起重要作用。 Objective To investigate the expression of PI3K, pAkt and FIEN, and to evaluate their effects on the tumorigenesis in nasopharyngeal carcinoma. Methods hnmtmohistochemical methods were adopted to examine the expression of PI3K, Akt and PTEN in 60 cases of nasopharyngeal carcinomas and 23 non-tumor nasopharyngeal tissue. Results In NPC and non-tumor cases, positive rates of PI3K were 86.7% (52/60) and 60.9% (14/23) ( P 〈 0.05), that of p-Akt were 76.7% (46/60) and 47.8% (11/23) ( P 〈 0.05), and that of PTEN 41.7% (25/60) and 65.2% (15/23) ( P 〈 0.01 ), respectively. Expression rates of PI3K/p-Akt in the NPC were significantly higher than the non-tumor, and that of PTEN in the NPC were significantly lower than the non-tumor. Conclusion The activation of PI3K/Akt pathway and the inhibition of PTEN expression may play important roles in the tumorigenesis and progression of nasophazyngeal carcinoma.
出处 《诊断病理学杂志》 CSCD 2009年第6期459-461,共3页 Chinese Journal of Diagnostic Pathology
关键词 鼻咽癌 PTEN PI3K P-AKT Nasopharyngeal carcinoma PTEN pI3K p-Akt
  • 相关文献

参考文献6

  • 1Shamji AF, Nghiem, P, Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology[J]. Mol Cell, 2003, 12(2) : 271 - 280.
  • 2Slomiany MG, Black LA, Kibbey MM, et al. JGF-1 induced vascular endothelial growth fator secretion in head and neck squamous cell carcinoma[J]. Biocham Biophys Res Commun, 2006, 342(3): 851 - 858.
  • 3Thompsom AD Ⅲ, Kakar SS, Insulin and IGF-1 regulate the expression of the pituitary tuomor transforming gene(PTTG) in breast tumor cells[J]. FEBS Lett, 2005:579(14) :3195 - 3200.
  • 4David D, Kyung S. Cross-talk between JGF-1 and TGF-β signaling pathways[J]. Cytokine Growth Factor Rev, 2006, 12( 1 ) :59 - 74.
  • 5刘民锋,罗剑,余险峰,唐启彬,陈勇军,邹声泉.PTEN和mTOR信号转导通路在胆管癌发展中作用的研究[J].中国普通外科杂志,2006,15(4):274-276. 被引量:13
  • 6李平,钟雪云,秦艳芳,林琛莅,贾晋萍.PTEN在人脑胶质瘤细胞中的表达及其对细胞增殖的影响[J].癌症,2007,26(3):247-251. 被引量:7

二级参考文献14

  • 1孙妍,曹玉文,陆天才,潘晓琳,李锋,苏拉,蒋金芳,常彬.宫颈上皮癌变过程中细胞分化的研究[J].癌症,2005,24(10):1184-1190. 被引量:6
  • 2洪柳,李青,陈广生,张丰,聂蕾,林圣彩.外源性RGS16基因稳定转染对胶质瘤C6细胞生长的影响[J].癌症,2006,25(1):51-55. 被引量:3
  • 3Gao N,Zhang Z,Jiang BH,et al.Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer[J].Biochem Biophys Res Commun,2003,310(4):1124-1132.
  • 4Vogt PK.PI 3 -kinase,mTOR,protein synthesis and cancer[J].Trends Mol Med,2001,(7)11:482 -484.
  • 5Findlay GM,Harrington LS,Lamb RF.TSC-2 tumor suppressor and regulation of mTOR signaling:linking cell growth and proliferation?[J].Curr Opin Genet Dev,2005,15(1):69 -76.
  • 6Huang S,Houghtom PJ.Targeting mTOR signaling for cancer therapy[J].Curr Opin Phamacol,2003,3(4):371 -377.
  • 7Xu G,Zhang W,Bertram P,et al.Pharmacogenomic profiling of the PI3 K/PTEN-AKT-mTOR pathway in common human tumor[J].Int J Oncol,2004,24(4):901 -908.
  • 8Yue Q, Groszer M, Gil J S, et al. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization [J]. Development, 2005,132(14) :3281-3291.
  • 9Beere H M, Hickman J A. Differentiation: a suitable strategy for cancer chemotherapy? [J]. Anticancer Drug Des, 1993,8(4) :299-322.
  • 10Cfistofano A D, Pesce B, Cordon-Cardo C, et al. PTEN is essential for embryonic development and tumour suppression [J]. Nat Genet, 1998,19(4):348-355.

共引文献16

同被引文献36

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部